4//SEC Filing
Campbell Shannon 4
Accession 0001415889-24-029481
CIK 0001701541other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 4:34 PM ET
Size
5.3 KB
Accession
0001415889-24-029481
Insider Transaction Report
Form 4
Campbell Shannon
Director
Transactions
- Award
Common Stock
2024-12-13$2.50/sh+4,500$11,250→ 8,865 total
Footnotes (2)
- [F1]These shares were issued in accordance with the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
- [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on December 12, 2024.
Documents
Issuer
Black Diamond Therapeutics, Inc.
CIK 0001701541
Entity typeother
Related Parties
1- filerCIK 0002018966
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 4:34 PM ET
- Size
- 5.3 KB